Silexion Therapeutics Corp. (SLXN)
NASDAQ · Healthcare
Silexion Therapeutics Corp. Shareholder Equity 2023–2025
Silexion Therapeutics Corp. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Silexion Therapeutics Corp. shareholder equity for the quarter ending December 31, 2025 were 2.6M, a 165.25% decrease year-over-year.
- Silexion Therapeutics Corp. shareholder equity for 2025 were 2.6M, a 165.25% decrease from 2024.
- Silexion Therapeutics Corp. shareholder equity for 2024 were -4.0M, a 74.22% decrease from 2023.
- Silexion Therapeutics Corp. shareholder equity for 2023 were -15.5M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Silexion Therapeutics Corp. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $3 |
| 2024 | $-4 |
| 2023 | $-15 |
| Silexion Therapeutics Corp. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $3 |
| 2024-12-31 | $-4 |
| 2023-12-31 | $-15 |
Silexion Therapeutics Corp. Shareholder Equity — FAQ
Silexion Therapeutics Corp. (SLXN) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SLXN's shareholder equity history?
The chart and table above show Silexion Therapeutics Corp.'s shareholder equity by year and by quarter, including the growth rate.